These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


383 related items for PubMed ID: 4199414

  • 1. The subunit structure of normal and hemophilic factor VIII.
    Shapiro GA, Andersen JC, Pizzo SV, McKee PA.
    J Clin Invest; 1973 Sep; 52(9):2198-210. PubMed ID: 4199414
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Studies on the purification and characterization of human factor 8.
    Marchesi SL, Shulman NR, Gralnick HR.
    J Clin Invest; 1972 Aug; 51(8):2151-61. PubMed ID: 4626584
    [Abstract] [Full Text] [Related]

  • 8. Purification and biological characterization of human hepatopoietin A, a polypeptide growth factor for hepatocytes.
    Zarnegar R, Michalopoulos G.
    Cancer Res; 1989 Jun 15; 49(12):3314-20. PubMed ID: 2524251
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Studies on the purification of antihemophilic factor (factor VIII). II. Separation of partially purified antihemophilic factor by gel filtration of plasma.
    Ratnoff OD, Kass L, Lang PD.
    J Clin Invest; 1969 May 15; 48(5):957-62. PubMed ID: 5780204
    [Abstract] [Full Text] [Related]

  • 11. Heterogeneity of human factor VIII. III. Transitions between forms of factor VIII present in cryoprecipitate and in cryosupernatant plasma.
    Over J, Bouma BN, Sixma JJ, Bolhuis PA, Vlooswijk RA.
    J Lab Clin Med; 1980 Mar 15; 95(3):323-34. PubMed ID: 7354239
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Survival of 125iodine-labeled Factor VIII in normals and patients with classic hemophilia. Observations on the heterogeneity of human Factor VIII.
    Over J, Sixma JJ, Bruïne MH, Trieschnigg MC, Vlooswijk RA, Beeser-Visser NH, Bouma BN.
    J Clin Invest; 1978 Aug 15; 62(2):223-34. PubMed ID: 670391
    [Abstract] [Full Text] [Related]

  • 14. Isolation of prekallikrein activator from guinea pig serum or plasma adsorbed to immune precipitates or celite: possible relationship to Hageman factor.
    Treloar MP, Pyle H, Ozge-Anwar AH, Takeuchi Y, Movat HZ.
    Eur J Immunol; 1972 Aug 15; 2(4):338-45. PubMed ID: 5083514
    [No Abstract] [Full Text] [Related]

  • 15. Human coagluation factor V purification and thrombin-catalyzed activation.
    Dahlbäck B.
    J Clin Invest; 1980 Sep 15; 66(3):583-91. PubMed ID: 7400329
    [Abstract] [Full Text] [Related]

  • 16. Isolation, subunit structure, and proteolytic modification of bovine factor VIII.
    Legaz ME, Weinstein MJ, Heldebrant CM, Davie EW.
    Ann N Y Acad Sci; 1975 Jan 20; 240():43-61. PubMed ID: 122888
    [Abstract] [Full Text] [Related]

  • 17. The effect of thrombin on human factor VIII. Cleavage of the factor VIII procoagulant protein during activation.
    Hoyer LW, Trabold NC.
    J Lab Clin Med; 1981 Jan 20; 97(1):50-64. PubMed ID: 6778941
    [Abstract] [Full Text] [Related]

  • 18. Quantitative assay of a plasma factor deficient in von Willebrand's disease that is necessary for platelet aggregation. Relationship to factor VIII procoagulant activity and antigen content.
    Weiss HJ, Hoyer LW, Rickles FR, Varma A, Rogers J.
    J Clin Invest; 1973 Nov 20; 52(11):2708-16. PubMed ID: 4542944
    [Abstract] [Full Text] [Related]

  • 19. Studies on the purification of thrombopoietin from kidney cell culture medium.
    McDonald TP, Cottrell M, Clift R, Khouri JA, Long MD.
    J Lab Clin Med; 1985 Aug 20; 106(2):162-74. PubMed ID: 4020244
    [Abstract] [Full Text] [Related]

  • 20. Factor VIII-bypassing activity of bovine tissue factor using the canine hemophilic model.
    O'Brien DP, Giles AR, Tate KM, Vehar GA.
    J Clin Invest; 1988 Jul 20; 82(1):206-11. PubMed ID: 3134399
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 20.